Policy Paper

Joint PhRMA - BIO Letter on IPR

PhRMA July 28, 2015

The Biotechnology Industry Organization writes to express their support for changes to H.R. 9, the Innovation Act, and S. 1137, the PATENT Act, to preserve the integrity of the Drug Price Competition and Patent Term Restoration Act (commonly referred to as Hatch-Waxman) and the Biologics Price Competition and Innovation Act (BPCIA).